Applications

1608 – Amnion membrane (human tissue) for topical treatment of ophthalmic disorders (caused by disease and/or trauma), and wound dressings for skin burns and ulcers on the craniofacial area, torso, and limbs

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

To inform the Prostheses List Advisory Committee.

Service or technology in this application

Amnion membrane is a tissue of human origin and the inner lining of the foetal membranes. It is semi- transparent; does not contain blood vessels and is 20-50 microns thick. It is comprised of five layers: the epithelium: a basement membrane; and compact, fibroblast and intermediate layers. Separated from the chorion and cryopreserved, the amnion membrane can be used for the topical treatment of ophthalmic disorders, disease and trauma and as a dressing for wounds.

Type: Therapeutic

Medical condition this application addresses

Treatment of the ocular surface when the integrity has been disrupted due to surgery, disease or chemicals and treatment of acute and chronic wounds on the surface of the body including burns, graft sites and ulcers.

Meetings to consider this application

  • PASC meeting: 16 to 17 April 2020
  • ESC meeting: 11 to 12 February 2021
  • MSAC meeting: 31 March to 1 April 2021